Pyoderma gangraenosum

Current Opinion in Rheumatology

Volumn 23, Issue 1, 2011, Pages 50-56

  Wollina, Uwe ^a   Haroske, Gunter ^b  

^a Department of Dermatology and Allergology ^*  (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

inflammatory bowel disease; monoclonal antibodies; mycophenolate mofetil; orphan disease; pyoderma gangraenosum; tumour necrosis factor alpha; tyrosine kinase

Indexed keywords

ADALIMUMAB; ALEFACEPT; CORTICOSTEROID; CYCLOSPORIN A; EFALIZUMAB; INFLIXIMAB; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PROTEIN TYROSINE PHOSPHATASE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; VISILIZUMAB;

ARTICLE; CELL MIGRATION; CLINICAL FEATURE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ERYTHEMA NODOSUM; EYE DISEASE; HUMAN; PREGNANCY; PRIORITY JOURNAL; PYODERMA GANGRENOSUM; STOMA; ULCERATIVE COLITIS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADRENAL CORTEX HORMONES; CYTOSKELETAL PROTEINS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATORY BOWEL DISEASES; MALE; PREGNANCY; PREGNANCY COMPLICATIONS; PROTEIN KINASES; PYODERMA GANGRENOSUM; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78650509599     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/BOR.0b013e328341152f     Document Type: Article

References (63)

1. Wollina U. Pyoderma gangrenosum: a review. Orphanet J Rare Dis 2007; 2:19.
2. Hong JB, Su YN, Chiu HC. Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome (PAPA syndrome): report of a sporadic case without an identifiable mutation in the CD2BP1 gene. J Am Acad Dermatol 2009; 61:533-535.
3. Goldfinger S. The inherited autoinflammatory syndrome: a decade of discovery. Trans Am Clin Climatol Assoc 2009; 120:413-418.
4. Veillette A, Rhee I, Souza CM, Davidson D. PEST family phosphatases in immunity, autoimmunity, and autoinflammatory disorders. Immunol Rev 2009; 228:312-324.
5. Waite AL, Schaner P, Richards N, et al. Pyrin modulates the intracellular distribution of PSTPIP1. PLoS One 2009; 4:e6147.
6. Andre MF, Aumâ?treO, Grateau G, et al. Longest form of CCTG microsatellite repeat in the promoter of the CD2BP1/PSTPIP1 gene is associated with aseptic abscesses and with Crohn disease in French patients. Dig Dis Sci 2009. [Epub ahead of print]
7. Chua RA, Mackelfresh J, Cohen C, et al. Disseminated pyoderma gangrenosum: role for vascular endothelial growth factor and hypoxia inducible factor-2. J Am Acad Dermatol 2009; 61:730-732.
8. Cohen PR. Neutrophilic dermatoses: a review of current treatment options. Am J Clin Dermatol 2009; 10:301-312.
9. Ruocco E, Sangiuliano S, Gravina AG, et al. Pyoderma gangrenosum: an updated review. J Eur Acad Dermatol Venereol 2009; 23:1008-1017.
10. Fahri D, Cosnes J, Zizi N, et al. Significance of erythema nodosum and pyoderma gangrenosum in inflammatory bowel diseases: a cohort study of 2402 patients. Medicine (Baltimore) 2008; 87:281-293.
11. Yuksel I, Basar O, Ataseven H, et al. Mucocutaneous manifestations in inflammatory bowel disease. Inflamm Bowel Dis 2009; 15:546-550.
12. Moravvej H, Razavi GM, Farshchian M, Malekzadeh R. Cutaneous manifestations in 404 Iranian patients with inflammatory bowel disease: a retrospective study. Indian J Dermatol Venereol Leprol 2008; 74:607-610.
13. Duarte AF, Nogueira A, Lisboa C, Azevedo F. Pyoderma gangrenosum: clinical, laboratory and therapeutic approaches. Review of 28 cases [in Portuguese]. Dermatol Online J 2009; 15:3.
14. Sung YH, Kwon I, Jo S, Park S. Factors affecting ostomy-related complications in Korea. J Wound Ostomy Continence Nurs 2010; 37:166-172.
15. Szymanski KM, St-Cyr D, Alam T, Kassouf W. External stoma and peristomal complications following radical cystectomy and ileal conduit diversion: a systematic review. Ostomy Wound Manage 2010; 56:28-35.
16. Funayama Y, Kumagai E, Takahashi K, et al. Early diagnosis and early corticosteroid administration improves healing of peristomal pyoderma gangrenosum in inflammatory bowel disease. Dis Colon Rectum 2009; 52:311-314.
17. Mansur AT, Balaban D, Goktay F, Takmaz S. Pyoderma gangrenosum on the breast: a case presentation and review of the published work. J Dermatol 2010; 37:107-110.
18. Schoemann MB, Zenn MR. Pyoderma gangrenosum following free transverse rectus abdominis myocutaneous breast reconstruction: a case report. Ann Plast Surg 2010; 64:151-154.
19. Nomura Y, Akiyama M, Nishie W, Shimizu H. Progressive refractory ulcer of the nipple: a quiz. Acta Derm Venereol 2009; 89:445-446.
20. Rietjens M, Cuccia G, Brenelli F, et al. A pyoderma gangrenosum following breast reconstruction: a rare cause of skin necrosis. Breast J 2009. [Epub ahead of print]
21. Schintler MV, Grohmann M, Donia C, et al. Management of an unfortunate triad after breast reconstruction: pyoderma gangrenosum, full-thickness chest wall defect and Acinetobacter baumannii infection. J Plast Reconstr Aesthet Surg 2010. [Epub ahead of print]
22. Garcovich S,Gatto A, Ferrara P, Garcovich A. Vulvar pyoderma gangrenosum in a child. Pediatr Dermatol 2009; 26:629-631.
23. Ho SA, Tan WP, Tan AW, et al. Scrotal pyoderma gangrenosum associated with Crohn's disease. Singapore Med J 2009; 50:e397-e400.
24. Kim TH, Oh SY, Myung SC. Pyoderma gangranosum of the penis. J Korean Med Sci 2009; 24:1200-1202.
25. Ecra E, Ahogo KC, Sangare A, et al. An uncommon localization of pyoderma gangrenosum on the penis of an HIV infected patient in the Ivory Coast [in French]. Bull Soc Pathol Exot 2009; 102:85-87.
26. Wierzbicka-Hainaut E, Le Naoures H, Bonneric-Malthieu F, et al. Recurring pyoderma gangrenosum in pregnancy [in French]. Ann Dermatol Venereol 2010; 137:225-229.
27. Poiraud C, Gagey-Caron V, Barbarot S, et al. Cutaneous, mucosal and systemic pyoderma gangrenosum [in French]. Ann Dermatol Venereol 2010; 137:212-215.
28. Ayestaray B, Dudrap E, Chartaux E, et al. Necrotizing pyoderma gangrenosum: an unusual differential diagnosis of necrotizing fasciitis. J Plast Reconstr Aesthet Surg 2010. [Epub ahead of print]
29. Barr KL, Chhatwal HK, Wesson SK, et al. Pyoderma gangrenosum masquerading as necrotizing fasciitis. Am J Otolaryngol 2009; 30:273-276.
30. Verma SB. Atypical pyoderma gangrenosum following total knee replacement surgery: first report in dermatologic literature. An Bras Dermatol 2009; 84:689-691.
31. Miller L, Yentzer BA, Clark A, et al. Pyoderma gangrenosum: a review and update on new therapies. J Am Acad Dermatol 2010; 62:646-654.
32. Eaton PA, Callen JP. Mycophenolate mofetil as therapy for pyoderma gangrenosum. Arch Dermatol 2009; 145:781-785.
33. De Zwaan SE, Iland HJ, Damian DL. Treatment of refractory pyoderma gangrenosum with intravenous immunoglobulin. Australas J Dermatol 2009; 50:56-59.
34. Sockolov ME, Alikhan A, Zargari O. Nonpsoriatic dermatologic uses of monoclonal antibody therapy. J Dermatolog Treat 2009; 20:319-327.
35. Brooklyn TN, Dunnill MG, Shetty A, et al. Infliximab for the treatment of pyoderma gangrenosum: a randomized, double blind, placebo controlled trial. Gut 2006; 33:505-509.
36. Fonder MA, Cummins DL, Ehst BD, et al. Adalimumab therapy for recalcitrant pyoderma gangrenosum. J Burns Wounds 2006; 5:e8.
37. Roy DB, Conte ET, Cohen DJ. The treatment of pyoderma gangraenosum using etanercept. J Am Acad Dermatol 2006; 54 (Suppl 2):S128-S134.
38. Pastor N, Betlloch I, Pascual JC, et al. Pyoderma gangrenosum treated with anti-TNF alpha therapy (etanercept). Clin Exp Dermatol 2006; 31:152-153.
39. Dini V, Romanelli M, Bertone M, et al. Improvement of idiopathic pyoderma gangrenosum during treatment with antitumor necrosis factor alpha monoclonal antibody. Int J Low Extrem Wounds 2007; 6:108-113.
40. Charles CA, Leon A, Banta MR, Kirsner RS. Etanercept for the treatment of refractory pyoderma gangrenosum: a brief series. Int J Dermatol 2007; 46:1095-1099.
41. Pomerantz RG, Husni ME, Mody E, Qureshi AA. Adalimumab for treatment of pyoderma gangrenosum. Br J Dermatol 2007; 157:1274-1275.
42. Heffernan MP, Anadkat MJ, Smith DI. Adalimumab treatment for pyoderma gangrenosum. Arch Dermatol 2007; 143:306-308.
43. Carrera C, Mascaró JM, Moreno-Romero JA, et al. Pyoderma vegetans associated with severe psoriatic arthritis: good response to etanercept. Dermatology 2007; 214:77-81.
44. Poritz LS, Lebo MA, Bobb AD, et al. Management of peristomal pyoderma gangrenosum. J Am Coll Surg 2008; 206:311-315.
45. Jacob SE, Weisman RS, Kerdel FA. Pyoderma gangrenosum: rebel without a cure? Int J Dermatol 2008; 47:192-194.
46. Marzano AV, Tourlaki A, Alessi E,Caputo R. Widespread idiopathic pyoderma gangrenosum evolved from ulcerative to vegetative type: a 10-year history with a recent response to infliximab. Clin Exp Dermatol 2008; 33:156-159.
47. Rogge FJ, Pacifico M, Kang N. Treatment of pyoderma gangrenosum with the anti-TNFalpha drug: Etanercept. J Plast Reconstr Aesthet Surg 2008; 61:431-433.
48. Adişen E, Oztaş M, Gürer MA. Treatment of idiopathic pyoderma gang-renosum with infliximab: induction dosing regimen or on-demand therapy? Dermatology 2008; 216:163-165.
49. Nozawa T, Hara R, Kinoshita J, et al. Infliximab for a girl with refractory pyoderma gangrenosum [in Japanese]. Nihon Rinsho Meneki Gakkai Kaishi 2008; 31:454-459.
50. Roche E, Mart́?nez-Menchón T, Sánchez-Carazo JL, et al. Two cases of eruptive pyoderma gangrenosum associated with cocaine use [in Spanish]. Actas Dermosifiliogr 2008; 99:727-730.
51. Fernández A, Velasco A, Prieto V, et al. Response to infliximab in atypical pyoderma gangrenosum associated with ulcerative colitis. Am J Gastroenterol 2008; 103:2951-2952.
52. Ermis F, Ozdil S, Akyüz F, et al. Pyoderma gangrenosum treated with infliximab in inactive ulcerative colitis. Inflamm Bowel Dis 2008; 14:1611-1613.
53. Goldshmid O, Dovorish Z, Zehavi T, et al. Coexistent pyoderma gangrenosum and tibialis anterior myositis as presenting manifestations of Crohn's disease: case report and review of the literature. Rheumatol Int 2009. [Epub ahead of print]
54. Rajan N, Das S, Taylor A, et al. Idiopathic infantile pyoderma gangrenosum with stridor responsive to infliximab. Pediatr Dermatol 2009; 26:65-69.
55. Wö lbing F, Fierlbeck G, Hö tzenecker W, et al., Septic shock after treatment of pyoderma gangrenosum with infliximab. Acta Derm Venereol. 2009, 89, 93-94.
56. Akhras V, Sarkany R, Walsh S, et al. Superficial granulomatous pyoderma treated preoperatively with infliximab. Clin Exp Dermatol 2009; 34:e183-e185.
57. Zold E, Nagy A, Devenyi K, et al. Successful use of adalimumab for treating fistulizing Crohn's disease with pyoderma gangrenosum: two birds with one stone. World J Gastroenterol 2009; 15:2293-2295.
58. Alkhouri N, Hupertz V, Mahajan L. Adalimumab treatment for peristomal pyoderma gangrenosum associated with Crohn's disease. Inflamm Bowel Dis 2009; 15:803-806.
59. Foss CE, Clark AR, Inabinet R, et al. An open-label pilot study of alefacept for the treatment of pyoderma gangrenosum. J Eur Acad Dermatol Venereol 2008; 22:943-949.
60. Lorincz M, Kleszky M, Szalóki T Jr, Szalóki T. Pyoderma gangrenosum treated successfully with visilizumab in patients with ulcerative colitis [in Hungarian]. Orv Hetil 2010; 151:144-147.
61. Brenner M, Ruzicka T, Plewig G, et al. Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinra. Br J Dermatol 2009; 161:1199-1201.
62. Marzano AV, Trevisan V, Lazzari R, Crosti C. Topical tacrolimus for the treatment of localized, idiopathic, newly diagnosed pyoderma gangrenosum. J Dermatolog Treat 2009. [Epub ahead of print]
63. Lucchina S, Parvex SL, Biegger P, Fusetti C. FK-506 ointment: an effective adjuvant therapy to treat a dramatic case of pyoderma gangrenosum of unilateral hand. Chin J Traumatol 2009; 12:181-183.